These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35426460)

  • 1. Optimization of adaptive designs with respect to a performance score.
    Herrmann C; Kieser M; Rauch G; Pilz M
    Biom J; 2022 Aug; 64(6):989-1006. PubMed ID: 35426460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal planning of adaptive two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2021 Jun; 40(13):3196-3213. PubMed ID: 33738842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal adaptive single-arm phase II trials under quantified uncertainty.
    Kunzmann K; Kieser M
    J Biopharm Stat; 2020; 30(1):89-103. PubMed ID: 31023135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
    Herrmann C; Pilz M; Kieser M; Rauch G
    Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extension of a conditional performance score for sample size recalculation rules to the setting of binary endpoints.
    Bokelmann B; Rauch G; Meis J; Kieser M; Herrmann C
    BMC Med Res Methodol; 2024 Jan; 24(1):15. PubMed ID: 38243169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal unplanned design modification in adaptive two-stage trials.
    Pilz M; Herrmann C; Rauch G; Kieser M
    Pharm Stat; 2022 Nov; 21(6):1121-1137. PubMed ID: 35604767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal flexible sample size design with robust power.
    Zhang L; Cui L; Yang B
    Stat Med; 2016 Aug; 35(19):3385-96. PubMed ID: 26999385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive two-stage designs in phase II clinical trials.
    Banerjee A; Tsiatis AA
    Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal adaptive group sequential design with flexible timing of sample size determination.
    Cui L; Zhang L; Yang B
    Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the efficiency of adaptive sample size design.
    Cui L; Zhang L
    Stat Med; 2019 Mar; 38(6):933-944. PubMed ID: 30450621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising zone two-stage design for a single-arm study with binary outcome.
    Shan G
    Stat Methods Med Res; 2023 Jun; 32(6):1159-1168. PubMed ID: 36998163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended two-stage adaptive designs with three target responses for phase II clinical trials.
    Kim S; Wong WK
    Stat Methods Med Res; 2018 Dec; 27(12):3628-3642. PubMed ID: 28535716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials.
    Flight L; Julious S; Brennan A; Todd S
    Med Decis Making; 2022 May; 42(4):461-473. PubMed ID: 34859693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints.
    Meis J; Pilz M; Bokelmann B; Herrmann C; Rauch G; Kieser M
    Stat Med; 2024 Apr; 43(8):1577-1603. PubMed ID: 38339872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal adaptive promising zone designs.
    Mehta C; Bhingare A; Liu L; Senchaudhuri P
    Stat Med; 2022 May; 41(11):1950-1970. PubMed ID: 35165917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A variational approach to optimal two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2019 Sep; 38(21):4159-4171. PubMed ID: 31264243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasonable two-stage adaptive designs for single-arm phase II clinical trials.
    Kashiwabara K; Matsuyama Y
    Pharm Stat; 2018 Nov; 17(6):770-780. PubMed ID: 30168250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs.
    Herrmann C; Rauch G
    Methods Inf Med; 2021 May; 60(1-02):1-8. PubMed ID: 33648007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.